The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Toxicogenomics and Pharmacogenomics Research in Health Disparities
Abstract
In recent years, the fields of toxicogenomics and pharmacogenomics have become increasingly popular as scientists attempt to understand the intricate interactions between genetic variables, environmental exposures, and how these factors affect health outcomes like the onset of diseases and the efficacy of medical treatments. This method has grown in significance for comprehending and resolving health inequalities. Significant racial and ethnic differences in drug response are revealed by combining genetic ancestry and pharmacogenomic data, which can help address health disparities and guide personalized medicine. These fields leverage genetic data to tailor medical treatments, aiming to reduce adverse drug reactions and improve therapeutic efficacy. Understanding these mechanisms are crucial to developing more personalized and effective treatments that account for individual genetic differences and their impact on how people respond to medications. The important developments in the field of omics to comprehend and reduce health disparities are covered in this chapter.
Related Content
|
Christopher Oloruntoba Akintayo, Samuel O. Onyekweli, Gloria Osayamen Omoruyi, Tobi O. Olaleye, Oluwakemi M. Olowomeye, Victor O. Osundele, Paul A. Oyewole.
© 2026.
106 pages.
|
|
S. Athinarayanan, K. Dhanakodi, R. Kavitha, M. Robinson Joel, S. Athinarayanan, A.T. Rajamanickam, A. Sanjaygandhi, S. Muthukumar.
© 2026.
30 pages.
|
|
Mamta Singh.
© 2026.
38 pages.
|
|
Shivani Nandkishor Bhave, Smriti Das, Akhilesh Prajapati.
© 2026.
82 pages.
|
|
Duygu Aygunes Jafari, Canfeza Sezgin, Buket Kosova.
© 2026.
44 pages.
|
|
Surendra Prakash Gupta, Ankur Bhardwaj.
© 2026.
28 pages.
|
|
Merve Saide Uzunoglu, Sümeyya Çapuk, Aylin Seher Uzunoglu, Sevgi Kalkanli Taş.
© 2026.
30 pages.
|
|
|